Home › Cardiome Pharma Corp (CRME) Receives "Buy" Rating from Canaccord Genuity
 

Keywords :   


Cardiome Pharma Corp (CRME) Receives "Buy" Rating from Canaccord Genuity

2016-03-13 15:32:23| Biotech - Topix.net

's stock had its "buy" rating reaffirmed by investment analysts at Canaccord Genuity in a research report issued on Sunday, AnalystRatings.NET reports. They presently have a $10.00 target price on the biopharmaceutical company's stock.

Tags: buy rating corp receives

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Boeing strike ends as workers back 38% pay rise deal
05.11Tropical Storm Rafael Public Advisory Number 6A
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Graphics
05.11Atlantic Tropical Weather Outlook
05.11Eastern North Pacific Tropical Weather Outlook
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
More »